natgillin/translations-raw huggingface dataset:
21-chloro-16-alpha-methylpregna-1,4,9(11)-triene-3,20-dione
Systematický názov (pokiaľ je odlišný)
trans-2-chloro-3-[4-(4-chlorophenyl)cyclohexyl]-1,4-naphthoquinone
acetát
4,6-difluoroindan-1-one
acetofenid
(2-bromo-5-propoxyphenyl)(2-hydroxy-4-methoxyphenyl)methanone
propán-2,2-diylbis(oxy) (INNCN)
17-alpha-hydroxy-16-beta-methyl-3,20-dioxopregna-1,4,9(11)-trien-21-yl acetate
N-acetylglycinát (INNCN)
20-oxopregna-5,16-dien-3-beta-yl acetate
acetylsalicylát
2-oxo-2-phenylethyl acetate
2-(acetyloxy)benzoát
17-hydroxy-16-alpha-methyl-3,20-dioxopregna-1,4,9(11)-trien-21-yl acetate
acibutát (INNRG)
2-acetoxy-5-acetylbenzyl acetate
acetát (ester), 2-metylpropanoát (ester) (INNCN)
17-alpha-hydroxy-16-alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate
acistrát (INNRG)
17-alpha-hydroxy-16-beta-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate
acetát (ester), oktadekanoát (ester) (INNCN)
3,20-dioxopregna-1,4,9(11),16-tetraen-21-yl acetate
adipát
(1S,4R)-4-hydroxycyclopent-2-en-1-yl acetate
hexándioát akoxil (INNRG)
2-(acetoxymethyl)-4-iodobutyl acetate
(acetyloxy)metyl (INNCN)
2-(acetoxymethyl)-4-(benzyloxy)butyl acetate
alaninát (INNRG)
1-bromo-2-methylpropyl propionate
L-alaninát (INNCN)
iodomethyl pivalate
L-alanyl, [(2,2-dimetylpropanoyl)oxy]metyl (INNCN)
pentyl chloroformate
(4-iminobután-1,4-diyl)sulfándiyl[(3RS)-2,5-dioxopyrolidín-1,3-diyl]-1,3-fenylénkarbonyl a vytvárajúci N-benzoylový derivát primárnej aminoskupiny peptidu difterického toxínu [550-L-fenylalanín] z Corynebacterium difteriae-(26-560) (INNCN)
sodium 2-propylpentanoate
alfoscerát (INNRG)
4-methoxyphenyl chloroformate
benzoát (INNRG)
chloromethyl pivalate
besilát (INNRG)
(3R)-3-methylhexanoic acid
besylát
cyclobutanecarboxylic acid
trans-4-butylcyklohexánkarboxylát (INNCN)
trans-4-(propan-2-yl)cyclohexanecarboxylic acid
bunapsilát (INNRG)
4,4-difluorocyclohexane-1-carboxylic acid
3,7-di-terc-butylnaftalén-1,5-disulfónan (INNCN)
1-(2-ethylbutyl)cyclohexanecarbonyl chloride
buteprát (INNRG)
1-(2-ethylbutyl)cyclohexanecarboxylic acid
butyrát (ester), propionát (ester) (INNCN)
(2S,3S)-2,3-bis(benzoyloxymethyl)cyclobutanone
rac-2,3-dihydroxypropyl karbonát (ester) (INNCN) chinát
(1S,2S,3S)-2,3-bis(benzoyloxymethyl)cyclobutanol
chlorid železa
sodium 4-phenylbutanoate
cholín
methyl 4-(bromomethyl)benzoate
rac-1-[(cyklohexyloxy)karbonyl]oxyetyl (INNCN)
(2-chlorophenyl)acetic acid
cinamát
ethyl 2-methyl-2-phenylpropanoate
cipionát (INNRG)
2-(2,4,6-triisopropylphenyl)acetic acid
citrát
sodium hydrogen 3-sulfonatobenzoate
2-hydroxypropán-1,2,3-trikarboxylát
5-fluoro-2-methylbenzoyl chloride
cituxetán (INNRG)
2-bromo-2-(2-chlorophenyl)acetic acid
cyklamát (INNRG)
4-bromo-2,2-diphenylbutyric acid
N-cyklohexylsulfamát, N-cyklohexylsulphamát
trans-4-(p-chlorophenyl)cyclohexanecarboxylic acid
cyklohexylsulfamát (INNCN)
(S)-2-(4-fluorophenyl)-3-methylbutyric acid
cyklohexylamín
2-chloro-4,5-difluorobenzoic acid
disulfid
tert-butyl 4′-(bromomethyl)biphenyl-2-carboxylate
disulphid
4,6-dibromo-3-fluoro-o-toluic acid
dofosfát (INNRG)
magnesium bis(4-nitrobenzyl malonate) dihydrate
oktadecyl hydrogen fosfát (INNCN)
diethyl ethyl(pentan-2-yl)propanedioate
draslík (INNRG)
diethyl dipropylmalonate
draslík (INNCN)
dimethyl chloromalonate
etabonát (INNRG) etylkarbonát (INNCN)
(E)-oct-4-ene-1,8-dioic acid
etexilát (INNRG)
triethyl 3-bromopropane-1,1,1-tricarboxylate
etilsulfát (INNRG)
phenyl hydrogen phenylmalonate
etylsulfát etyl sulfát (INNCN)
indan-5-yl hydrogen phenylmalonate
etylamín
dibenzoyl-L-tartaric acid
etylamónium
calcium gluconate lactate
etylbromid
(3R,4S,5R)-3,4,5-trihydroxycyclohex-1-ene-1-carboxylic acid
etobromid
D-mandelic acid
N-etyl, bromid (soľ)
ethyl DL-mandelate
etylénantát
methyl (R)-3-hydroxybutyrate
etán-1,2-diamím
cyclohexyl(hydroxy)phenylacetic acid
etyl ester
(2S)-cyclohexyl(hydroxy)phenylacetic acid
etylhexanoát
(R)-alpha-(chlorocarbonyl)benzyl formate
etyljodid
(S)-alpha-chloroformylethyl acetate
etylsukcinát
(2R)-(2-chlorophenyl)hydroxyacetic acid
esylát, etánsulfónan, etánsulphónan
(1R,3R,5S)-3,5-dihydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]cyclopentylacetic acid
etánsulfónan (INNCN)
ammonium (3R,5R)-7-(1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-2,6-dimethyl-8-[(2S)-2-methylbutyryloxy]-1-naphthyl-3,5-dihydroxyheptanoate
fluorid
ethyl (R)-2-hydroxy-4-phenylbutyrate
fluórsulfónan
(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl dihydroxyacetate or thymol glyoxylate
tetradecyl hydrogen fosfát (INNCN)
ammonium (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-2,6-dimethyl-1-naphthyl]-3,5-dihydroxyheptanoate
ftalát
disodium (2S,3R)-2-hydroxy-3-isobutylsuccinate
benzén-1,2-dikarboxylát
ethyl 3,4-dihydroxybenzoate
fumarát (2E)-but-2-éndioát
3-chloroformyl-o-tolyl acetate
furetonid (INNRG) 1-benzofurán-2-karboxylát (ester), propán-2,2-diylbis(oxy) (INNCN)
3-acetoxy-o-toluic acid
furoát
5′-chloro-2′-hydroxy-3′-nitrobiphenyl-3-carboxylic acid
furán-2(alebo 3)-karboxylát
3-oxoandrost-4-ene-17-beta-carboxylic acid
fusidát
3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxooctahydro-1H-inden-4-yl]propionic acid
gadolínium gáforát
ketoprofen (INN) ((RS)-2-(3-benzoylphenyl)propionic acid)
1,2,2-trimetyl-1,3-cyklopentándikarboxylát
ethyl (E)-2-(3-nitrobenzylidene)-3-oxobutanoate
gamolenát (INNRG) (6Z,9Z,12Z)-oktadeka-6,9,12-trienoát (INNCN)
methyl 2-(3-nitrobenzylidene)-3-oxobutyrate
glargín (INNRG)
2-methoxyethyl (E)-2-(3-nitrobenzylidene)-3-oxobutanoate
21A-glycín-30Bα-L-arginín-30Bβ-L-arginín (INNCN)
methyl (2E)-2-(2-nitrobenzylidene)-3-oxobutanoate
gluceptát (INNRG)
(R)-2-(3-benzoylphenyl)propionic acid
glukoheptonát
ethyl 2-oxo-4-phenylbutyrate
D-glycero-D-gulo-heptonát (INNCN)
ethyl 7-chloro-2-oxoheptanoate
glukarát
ethyl 3-(2-chloro-4,5-difluorophenyl)-3-hydroxyacrylate
sacharát
ethyl 2-oxobicyclo[3.1.0]hexane-6-carboxylate
(2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexándioát, D-glukarát
5-(4-fluorophenyl)-5-oxopentanoic acid
glukonát
diethyl ethoxymethylenemalonate
glukozid
(4-butyryl-2,3-dichlorophenoxy)acetic acid
glukuronid (INNRG)
(3α,5β)-3-hydroxy-7-oxocholan-24-oic acid
kyselina β-D-glukopyranozidurónová [-ozid] (INNCN)
(2,6-dimethylphenoxy)acetic acid
glulizín (INNRG)
(RS)-2-(6-methoxy-2-naphthyl)propionic acid
3B-L-lyzín,29B-L-kyselina glutamínová (INNCN)
6-alpha,9-difluoro-11-beta,17-alpha-dihydroxy-16-alpha-methyl-3-oxoandrosta-1,4-diene-17-beta-carboxylic acid
polymér glutaraldehydu (INNCN)
methyl 5-glyoxyloylsalicylate hydrate
glykolát
4-(4-phenylbutoxy)benzoic acid
hydroxyacetát
methyl 5-chloro-o-anisate
glyoxylát
2,5-bis(2,2,2-trifluoroethoxy)benzoic acid
oxoacetát
methyl 7-[(3RS)-3-hydroxy-5-oxocyclopent-1-enyl]heptanoate
guacil (INNRG)
ethyl 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoate
2-metoxyfenyl (INNCN)
methyl 4-(bromomethyl)-m-anisate
guanidín hemisukcinát (INNRG)
isobutyl 3,4-epoxybutyrate
hydrogen sukcinát
methyl (2R,3S)-2,3-epoxy-3-(4-methoxyphenyl)propionate
hydrogén butándioát (INNCN)
dimethyl (2-methoxyphenoxy)malonate
hexacetonid (INNRG)
ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
3,3-dimetylbutanoát (ester), propán-2,2-diylbis(oxy) (INNCN)
methyl 3-(5-[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl-2-hydroxyphenyl)propanoate
hibenzát (INNRG) hybenzát
(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)acetic acid
4-(4-hydroxybenzoyl)benzoát (INNCN) hipurát
(R)-propylene carbonate
N-benzoylglycín, soľ horčík hydrát hydrobromid hydrochlorid hydroxid
chloromethyl isopropyl carbonate
hydroxybenzoát
4-(chloromethyl)-5-methyl-1,3-dioxol-2-one
2-(4-hydroxybenzoyl)benzoát o-(4-hydroxybenzoyl)benzoát
4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one
hydroxynaftoát (INNRG)
(4R,5R)-4,5-bis(mesyloxymethyl)-1,3,2-dioxathiolane 2,2-dioxide
hydroxynaphtoát 3-hydroxynaftalén-2-karboxylát (INNCN)
diisopropyl phosphorofluoridate
hyklát (INNRG)
5,7-dioxa-6-thiaspiro[2.5]octane 6-oxide
etanol – chlorovodík – voda (0,5/1/0,5) (INNCN) isetionát (INNRG)
(2-chloroethyl)diisopropylamine hydrochloride
2-hydroxyetán-1-sulfónan (INNCN)
3-chloropropyldimethylammonium chloride
izobutyrát
2-aminoethyldiethylamine
2-metylpropanoát
N,N′-bis[3-(ethylamino)propyl]propane-1,3-diamine tetrahydrochloride
izoftalát
cyclohexylammonium 1-[(S)-2-(tert-butoxycarbonyl)-3-(2-methoxyethoxy)propyl]cyclopentanecarboxylate
benzén-1,3-dikarboxylát izokaproát
4-amino-6-chlorobenzene-1,3-di(sulfonyl chloride)
4-metylpentanoát
alpha,alpha,alpha-trifluoro-4-nitro-m-toluidine
izonikotinát
2-chlorobenzylamine
pyridín-4-karboxylát izopropionát
benzyl(methyl)amine
izopropyl propan-2-yl
alpha,alpha,alpha,alpha′,alpha′,alpha′-hexafluoro-2,5-xylidine
malát
3-(5H-dibenzo[a,d]cyclohepten-5-ylpropyl)dimethylammonium chloride
(Z)-but-2-enoát
(1S)-1-phenylpropan-1-amine
malonát
alpha′,alpha′,alpha′-trifluoro-2,3-xylidine
mandelát
2,6-difluorobenzylamine
2-hydroxy-2-fenylacetát, α-hydroxybenzénacetát
trans-(±)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthyl(methyl)ammonium chloride
1-deoxy-1-metylamino-D-glucitol
3-(trichlorovinyl)aniline hydrochloride
merpentán (INNRG)
1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine
N,N′-[1-(3-oxopropyl)etán-1,2-diyl]bis(2-sulfanylacetamidato)(4-) (INNCN)
triethylaniline
mertanzín (INNRG)
1-ethyl-1,4-diphenylbut-3-enylamine
nafát
(Z)-N-[3-(3-chloro-4-cyclohexylphenyl)prop-2-enyl]-N-ethylcyclohexylamine hydrochloride
formiát sodný
methyl(4′-nitrophenethyl)amine hydrochloride
oxalát
(1R)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine D-tartrate (1:1)
oxid
(1R)-1-[3,5-bis(trifluoromethyl)phenyl]-N-methylethanamine
oxoglurát (INNRG)
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate
hydrogen 2-oxopentándioát (INNCN)
(1S)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine D-tartrate (1:1)
(RS)-1-[(2,2-dimetylpropanoyl)oxy]etyl (INNCN)
2-(4-chloro-3-ethylphenyl)ethanamine hydrochloride
perchlorát (INNRG)
N-(4-tert-butylbenzyl)-2-(4-chloro-3-ethylphenyl)ethanamine
2,4,6-trinitrobenzén-1-olát
2-(2,3-dihydro-1H-inden-2-yl)propan-2-amine hydrochloride
pivalát (INNRG)
N,N′-dibenzylethylenediammonium di(acetate)
2,2-dimetylpropanoát (ester) (INNCN)
N,N′-dibenzylethane-1,2-diamine
(R)-2-metyl-1-[(2-metylpropanoyl)oxy]propoxykarbonyl) (INNCN)
N4-[(4-fluorophenyl)methyl]-2-nitro-1,4-benzenediamine
propanan
antimonic acid–1-deoxy-1-(methylamino)-D-glucitol (1:1)
propanonát
2-aminopropane-1,3-diol
propyl
5-(3-dimethylaminopropyl)-10,11-dihydrodibenzo[a,d]cyclohepten-5-ol
rac-1-[(propán-2-yloxy)karbonyl]oxyetyl (INNCN)
1-deoxy-1-(octylamino)-D-glucitol
pyridinylacetát
(2R)-2-aminopropan-1-ol
(2S,4R,6R,8S,11S,13S)-2,4,8,13-tetrakis(hydroxymetyl)-4,6,11-tris(ylometyl)-3,5,7,10,12-pentaoxatetradekán-1,14-diyl (INNCN)
(2S,3R)-4-dimethylamino-3-methyl-1,2-diphenylbutan-2-ol
[(propán-2-yloxy)karbonyl]oxymetyl (INNCN)
2-(dimethylamino)-2-phenylbutan-1-ol
steaglát (INNRG)
3-(methylamino)-1-phenylpropan-1-ol
stinoprát (INNRG)
2-[benzyl(methyl)amino]ethyl acetoacetate
N-acetylcysteinát (soľ), propanoát (ester) (INNCN)
4-(benzyloxy)-α1-[(tert-butylamino)methyl]benzene-1,3-dimethanol
rac-(2R)-2,5,7,8-tetrametyl-2-[(4R,8R)-4,8,12-trimetyltridecyl]chróman-6-yl (INNCN)
4′-[2-(dimethylamino)ethoxy]-2-phenylbutyrophenone
tosilát (INNRG)
3-(Z)-1-[4-(2-dimethylaminoethoxy)phenyl]-2-phenylbut-1-enylphenol
tosylát, p-toluénsulfónan, p-toluénsulphonan
(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine hydrochloride
trifluóracetát (INNCN)
N-methyl-N-(4-nitrophenethyl)-2-(4-nitrophenoxy)ethan-1-amine
triklofenát (INNRG)
(1S,2R)-1-aminoindan-2-ol
2,4,5-trichlórfenolát (INNCN)
(1RS,2RS,3SR)-2,3-bis(benzoyloxymethyl)cyclobutylamine
trioleát (INNRG)
(R)-2-amino-2-ethylhexan-1-ol
Soli, estery alebo hydráty látok INN
((1S,4R)-4-aminocyclopent-2-en-1-yl)methanol hydrochloride
1-1-3-[2-(4-fluórfenyl)-1,3-dioxolán-2-yl]propyl-4-piperidyl-2,3-dihydro-1H-benzimidazol-2-tión
(S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol
intermediátový koncentrát získaný z fermentačného média geneticky modifikovanej Escherichia coli ,obsahujúci ľudský interferón α-(2b); na použitie pri výrobe liekov položky HS 3002
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoroethane-1,1-diol hydrochloride
intermediátový koncentrát získaný z fermentačného média Micromonospora inyoensis, používaný pri výrobe antibiotík sisomycínu (INN) a netilmycínu (INN)
(2S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol methanesulfonate (1:1.5)
Eidgenössische Zollverwaltung EZV – Oberzolldirektion – Sektion Tabak und Bierbesteuerung
ethyl 3-(3-[(2R)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino-2-hydroxypropyl]oxy-4,5-difluorophenyl)propanoate hydrochloride
Administration fédérale des Douanes AFD – Direction générale des Douanes – Section Imposition du tabac et de la bière
ethyl (2E)-3-(3-[(2R)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino-2-hydroxypropyl]oxy-4,5-difluorophenyl)prop-2-enoate hydrochloride
Amministrazione federale delle dogane AFD – Direzione generale delle dogane – Sezione Imposizione del tabacco e della birra
(2R)-1-(5-bromo-2,3-difluorophenoxy)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]aminopropan-2-ol hydrochloride
Swiss Customs Administration – Directorate-General – Tobacco and Beer taxation section
[2-(chloromethyl)-4-(dibenzylamino)phenyl]methanol hydrochloride
„Nosnosť v tonách“ (ct/l) znamená nosnosť plavidla vyjadrenú v tonách, do ktorej nepatria zásoby plavidla (palivo, zariadenie, zásoby potravín atď.).
3,4-dimethoxyphenethylamine
Nepatria sem osoby prepravované na palube (posádka a cestujúci) a ich batožina.
2-[4-(aminomethyl)phenoxy]-N,N-dimethylethanamine
L-lyzyl-L-alanyl-L-serylglycylglycín je spojujúcim článkom fúzneho proteínu s exotoxínom peptidu des-(365-380)-[Asn364,Val407,Ser515,Gln590,Gln606,Arg613] (Pseudomonas aeruginosa)-(251-613) (oblasťou IA toxínu a odstránenými prvými 16 aminokyselinovými zvyškami oblasti IB) (INNCN)
3,4-dimethoxy-beta-methylphenethylamine
boritan
4-(1-[2-(4-aminophenoxy)ethyl]methylaminoethyl)aniline
bromid (INNRG)
(2S)-hydroxy(phenyl)acetic acid—(2R)-N-benzyl-1-(4-methoxyphenyl)propan-2-amine (1:1) (salt)
buciklát (INNRG)
3-chloro-4-[(3-fluorobenzyl)oxy]aniline
butylbromid
2-amino-5-chloro-2′-fluorobenzophenone
t-butyl, terciárny butyl
2-amino-2′-chloro-5-nitrobenzophenone
terc-butyl ester
2-amino-2′,5-dichlorobenzophenone
butyrát
(2E)-3-(N-methylanilino)acrylaldehyde
butanoát
(S)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
1,3,4,5-tetrahydroxycyklohexánkarboxylát
dexibuprofen lysine (INNM)
chlorid (INNRG)
4-aminobutyric acid
ciklotát (INNRG)
D-alpha-phenylglycine
cyklotát
3-(4-nitrophenyl)-L-alanine
cypionát, cyklopentánpropionát
potassium (R)-N-(3-ethoxy-1-methyl-3-oxoprop-1-enyl)-2-phenylglycine
3-cyklopentylpropanoát (INNCN), 3-cyklopentylpropansn
diethyl L-glutamate hydrochloride
cyklohexylamónium
sodium (R)-N-(3-methoxy-1-methyl-3-oxoprop-1-enyl)-2-phenylglycinate
cyklohexylpropionát
methyl 3-aminocrotonate
Káliumklavulanát—mikrokryštalická celulóza (1:1)
2-cyclohexa-1,4-dienylglycine
Káliumklavulanát—oxid kremičitý (1:1)
sodium 2-(cyclohexa-1,4-dien-1-yl)-2-[((E)-1-methoxy-1-oxobut-2-en-2-yl)amino]acetate
Káliumklavulanát—sacharóza (1:1)
potassium (R)-N-(3-methoxy-1-methyl-3-oxoprop-1-enyl)-2-phenylglycinate
acetophenid
5-amino-2,4,6-triiodoisophthalic acid
1-fenyletán-1,1-diylbis(oxy)
5-amino-2,4,6-triiodoisophthaloyl dichloride
poly([oxy(2-hydroxyetán-1,1-diyl)]oxy[1-(hydroxymetyl)etán-1,2-diyl]) čiastočne O-éterifikovaný karboxymetylovými skupinami, pričom niektoré amidy karboxylových skupín sú naviazané na tetrapeptidový zvyšok (glycylglycyl-L-fenylalanylglycyl) (INNCN) alumínium (hliník)
methyl 2-(dimethylamino)-2-phenylbutanoate
benzylobromid
(-)-alpha-(chloroformyl)benzylammonium chloride
N-benzyl, bromid (soľ)
benzyl L-alaninate-p-toluenesulfonic acid (1:1)
bizmut
2-(N-methylbenzylamino)ethyl 3-aminobut-2-enoate
butylobromid
cis-4-(benzyloxycarbonyl)cyclohexylammonium tosylate
N-butyl, bromid (soľ)
methyl (4-nitrophenyl)-L-alaninate
terc-butyl
(S,S)-N-(1-ethoxycarbonyl-3-phenylpropyl)alanine
N-etyl, jodid (soľ)
N-[(2S)-1-ethoxy-1-oxopentan-2-yl]-L-alanine
Zoznam orgánov, ktoré môžu potvrdzovať osvedčenia
sodium 2-amino-2-phenylbutanoate
California Department of Food and Agriculture, Division of Inspection Services, Shipping Point Inspection, Sacramento, CA
methyl 3-amino-4,6-dibromo-o-toluate
Ministry of Trade Republic of Indonesia – Lembaga Tembakau Surakarte (Tobacco Institution in Surakarta)
3-(aminomethyl)-5-methylhexanoic acid
Ministry of Trade Republic of Indonesia – Regional Laboratory for testing and quality control and tobacco institution
4-(1-aminocyclopropyl)-2,3,5-trifluorobenzoic acid
Látka INN
ethyl (S)-3-aminopent-4-ynoate hydrochloride
1-acetoxyetyl
methyl 3′-aminobiphenyl-3-carboxylate
[(S)-1-etoxy-1-oxo-propán-2-yl]amino (INNCN)
2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid hydrate
(benzoyloxy)metyl (INNCN)
[(3S,4S)-1-(aminomethyl)-3,4-dimethylcyclopentyl]acetic acid
L-alaninát (ester), (5-metyl-2-oxo-1,3-dioxol-4-yl)metyl (INNCN)
(3S,5R)-3-amino-5-methyloctanoic acid hydrochloride
etyl
(3S,5R)-3-amino-5-methyloctanoic acid
plakarbil (INNRG)
(2E)-4-(dimethylamino)but-2-enoic acid hydrochloride
(9Z)-oktadec-9-enoát(1,5) (INNCN)
4-fluoro-L-leucine-ethyl hydrogen sulfate (1:1)
Languedoc–Roussillon
4-amino-5-chloro-2-methoxybenzoic acid
butylát
4-[1-hydroxy-2-(methylamino)ethyl]phenol-L-tartaric acid (2:1)
4-metylbicyklo[2.2.2]okt-2-én-1-karboxylát (INNCN)
D-2-(4-hydroxyphenyl)glycine
3-fenylprop-2-enoát
2-[benzyl(tert-butyl)amino]-1-(alpha,4-dihydroxy-m-tolyl)ethanol
triflutát (INNRG)
benzyl(tert-butyl)(4-hydroxy-3-hydroxymethyl-4-oxophenethyl)ammonium chloride
intermediátový koncentrát získaný z fermentačného média Micromonospora purpurea, používaný pri výrobe antibiotík gentamycín sulfátu (INN) a isepamycínu (INN)
sodium (R)-2-(4-hydroxyphenyl)-N-(3-methoxy-1-methyl-3-oxoprop-1-enyl)glycinate
10451 Stockholm
4′-benzyloxy-2-[(1-methyl-2-phenoxyethyl)amino]propiophenone hydrochloride
ceribát (INNRG)
4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol hydrochloride
cyklohexánkarboxylát (ester), cyklopropánkarboxylát (ester) (INNCN)
(2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid
2-(dimetylamino)etyl (INNCN)
potassium (R)-2-(4-hydroxyphenyl)-N-(3-methoxy-1-methyl-3-oxoprop-1-enyl)glycinate
des-B30-alanín (INNCN)
2-[benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride
2,6-di-terc-butylnaftalén-1-sulfónan (INNCN)
methyl hydrogen (2S,3R)-3-amino-2-[(S)-(1-hydroxyethyl)]glutarate
siričitan
3′-amino-2′-hydroxyacetophenone hydrochloride
Rīga, 1978
1-[4-(benzyloxy)phenyl]-2-[(4-phenylbutan-2-yl)amino]propan-1-one
3-(dimetylamino)propanoát (INNCN)
ethyl ((7S)-7-[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino-5,6,7,8-tetrahydro-2-naphthyloxy)acetate hydrochloride
t-butyl ester, terciárny butyl ester
ethyl 2-(2-chloro-4,5-difluorobenzoyl)-3-(2,4-difluoroanilino)acrylate
butyl ester
(1R)-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethan-1-ol
dicyklohexylmetyl karbonát (INNCN)
methyl N-(2-benzoylphenyl)-L-tyrosinate
dicyklohexylamónium
triphenylacetic acid-4-(1R)-2-[(6-2-[(2,6-dichlorobenzyl)oxy]ethoxyhexyl)amino]-1-hydroxyethyl-2-(hydroxymethyl)phenol (1:1)
kg/net mas
1,2-dioleoyl-sn-glycero-3-phosphocholine
(2-hydroxyetyl)trimetylamónium
2-O-methyl-1-O-octadecyl-sn-glycero-3-phosphocholine
cipecilát (INNRG)
2-carbamoyloxypropyltrimethylammonium chloride
N-(4-(2S)-2-[bis(karboxymetyl)amino]-3-[(2RS)-2-[bis(karboxymetyl)amino]propyl(karboxymetyl)amino]propylfenyl) tiokarbamoyl (INNCN)
N-(2-hydroxyethyl)lactamide
termín „smart karty“ znamená karty, ktoré majú v sebe zabudovaný jeden alebo viac elektronických integrovaných obvodov (mikroprocesor, pamäť s priamym prístupom (RAM) alebo pamäť určenú iba na čítanie – pevná pamäť (ROM) vo forme čipov.
L-asparagine hydrate
Tieto karty môžu obsahovať kontakty, magnetický prúžok alebo zabudovanú anténu, ale neobsahujú iné aktívne alebo pasívne obvodové prvky.
N-(2-chloroethyl)acetamide
žiadna doplnková jednotka
2-aminomalonamide
DRUHÁ ČASŤ
1-deoxy-1-formamidohexitol
Ostatné
N-[N-(tert-butoxycarbonyl)-L-alanyl]-L-alanine hydrate
(9 + EA) MAX (18,7 + AD S/Z)
2-(ethylmethylamino)acetamide
(9 + EA) MAX (20,7 + AD F/M)
(S)-3-formamido-2-formyloxypropionic acid
televízne kamery, digitálne fotoaparáty a videokamery;
(2S)-2-amino-3-hydroxy-N-pentylpropionamide-oxalic acid (1:1)
Rīga, 1301
N-(methoxycarbonyl)-3-methyl-L-valine
00101 Helsinki
(2S)-2-[3-(tert-butoxycarbonyl)-2,2-dimethylpropanoyl]oxy-4-methylpentanoic acid
00101 Helsingfors
1,2-dioleoyl-sn-glycero-3-phospho[N-(4-carboxybutanoyl)ethanolamine]
cilexetil (INNRG)
N-acetylsulfanilyl chloride
des-1B-L-fenylalanín-inzulín (INNCN)
N-benzyloxycarbonyl-L-alanine
tetradekanoyl (INNCN)
N-(benzyloxycarbonyl)-L-valine
dibudinát (INNRG)
2-bromo-4′-chloro-2′-(2-fluorobenzoyl)acetanilide
2,6-di-terc-butylnaftalén-1,5-disulfónan (INNCN)
2-methyl-N-(alpha,alpha,alpha-trifluoro-m-tolyl)propionamide
isethionát, 2-hydroxyetánsulfónan, 2-hydroxyetánsulfonát
N-benzyloxycarbonyl-DL-valine
enterotoxín A (227-alanín) (Staphylococcus aureus) (INNCN)
Council Implementing Regulation (EU) 2018/1604
Vykonávacie nariadenie Rady (EÚ) 2018/1604
implementing Regulation (EU) No 1284/2009 imposing certain specific restrictive measures in respect of the Republic of Guinea
ktorým sa vykonáva nariadenie (EÚ) č. 1284/2009, ktorým sa zavádzajú určité osobitné reštriktívne opatrenia voči Guinejskej republike
Having regard to Council Regulation (EU) No 1284/2009 of 22 December 2009 imposing certain specific restrictive measures in respect of the Republic of Guinea, and in particular Article 15a(4) thereof,
so zreteľom na nariadenie Rady (EÚ) č. 1284/2009 z 22. decembra 2009, ktorým sa zavádzajú určité osobitné reštriktívne opatrenia voči Guinejskej republike, a najmä na jeho článok 15a ods. 4,
On 22 December 2009, the Council adopted Regulation (EU) No 1284/2009.
Rada 22. decembra 2009 prijala nariadenie (EÚ) č. 1284/2009.
The information concerning the military rank of two of the persons listed in Annex II to Regulation (EU) No 1284/2009 should be updated.
Mali by sa aktualizovať informácie týkajúce sa vojenskej hodnosti dvoch osôb uvedených v zozname v prílohe II k nariadeniu (EÚ) č. 1284/2009.
Regulation (EU) No 1284/2009 should therefore be amended accordingly,
Nariadenie (EÚ) č. 1284/2009 by sa preto malo zodpovedajúcim spôsobom zmeniť,
Annex II to Regulation (EU) No 1284/2009 is replaced by the text set out in the Annex to this Regulation.
Príloha II k nariadeniu (EÚ) č. 1284/2009 sa nahrádza znením uvedeným v prílohe k tomuto nariadeniu.
OJ L 346, 23.12.2009, p. 26.
Ú. v. EÚ L 346, 23.12.2009, s. 26.
LIST OF NATURAL AND LEGAL PERSONS, ENTITIES OR BODIES REFERRED TO IN ARTICLE 6(3)
ZOZNAM FYZICKÝCH A PRÁVNICKÝCH OSÔB, SUBJEKTOV ALEBO ORGÁNOV PODĽA ČLÁNKU 6 ODS. 3
d.o.b.: 1.1.64 or 29.12.68
dátum nar.: 1.1.1964 alebo 29.12.1968
Pass: R0001318
číslo pasu: R0001318
Person identified by the International Commission of Inquiry as responsible for the 28 September 2009 events in Guinea
Osoba, o ktorej medzinárodná vyšetrovacia komisia zistila, že je zodpovedná za udalosti, ktoré sa v Guinei odohrali 28. septembra 2009.
Colonel Moussa Tiégboro CAMARA
plukovník Moussa Tiégboro CAMARA
d.o.b.: 1.1.68
dátum nar.: 1.1.1968
Pass: 7190
číslo pasu: 7190
d.o.b.: 26.2.57
dátum nar.: 26.2.1957
Pass: 13683
číslo pasu: 13683
Colonel Jean-Claude PIVI (alias Coplan)
plukovník Jean-Claude PIVI (alias Coplan)
d.o.b.: 1.1.60
dátum nar.: 1.1.1960
Council Implementing Regulation (EU) 2018/1605
Vykonávacie nariadenie Rady (EÚ) 2018/1605
implementing Regulation (EU) 2015/1755 concerning restrictive measures in view of the situation in Burundi
ktorým sa mení nariadenie (EÚ) 2015/1755 o reštriktívnych opatreniach vzhľadom na situáciu v Burundi
Having regard to Council Regulation (EU) 2015/1755 of 1 October 2015 concerning restrictive measures in view of the situation in Burundi, and in particular Article 13(4) thereof,
so zreteľom na nariadenie Rady (EÚ) 2015/1755 z 1. októbra 2015 o reštriktívnych opatreniach vzhľadom na situáciu v Burundi, a najmä na jeho článok 13 ods. 4,
On 1 October 2015, the Council adopted Regulation (EU) 2015/1755 concerning restrictive measures in view of the situation in Burundi.
Rada 1. októbra 2015 prijala nariadenie (EÚ) 2015/1755 o reštriktívnych opatreniach vzhľadom na situáciu v Burundi.